Guidelines for Managing Acute Respiratory Distress Syndrome (ARDS)
The management of ARDS should follow a lung-protective strategy with low tidal volumes (4-8 mL/kg predicted body weight), low inspiratory pressures (plateau pressure ≤30 cmH2O), and appropriate PEEP based on ARDS severity. 1, 2
Definition and Classification
ARDS is characterized by:
- Acute onset within one week of a known clinical insult
- Bilateral opacities on chest imaging not fully explained by effusions, collapse, or nodules
- Respiratory failure not explained by cardiac failure or fluid overload
- Hypoxemia with PaO₂/FiO₂ ratio ≤300 mmHg with PEEP ≥5 cmH₂O
Severity classification:
- Mild: PaO₂/FiO₂ 201-300 mmHg
- Moderate: PaO₂/FiO₂ 101-200 mmHg
- Severe: PaO₂/FiO₂ ≤100 mmHg
Core Management Strategies
1. Mechanical Ventilation (Strong Recommendations)
- Lung-protective ventilation: Use tidal volumes of 4-8 mL/kg predicted body weight and maintain plateau pressure <30 cmH₂O 1
- PEEP strategy:
2. Adjunctive Therapies
- Prone positioning: Strongly recommended for severe ARDS for >12 hours/day (ideally 16-20 hours), implemented early (within first 48 hours) 1, 2
- Corticosteroids: Suggested for all ARDS patients to reduce inflammatory response and pulmonary edema 1, 2
- Neuromuscular blocking agents: Suggested for early severe ARDS (first 48 hours) to prevent patient-ventilator dyssynchrony 1, 2
- VV-ECMO: Suggested in selected patients with severe ARDS who fail conventional management 1
- High-frequency oscillatory ventilation: Strongly recommended against routine use in moderate or severe ARDS 1
Management Algorithm Based on ARDS Severity
For All ARDS Patients:
- Implement lung-protective ventilation (4-8 mL/kg PBW, plateau pressure <30 cmH₂O)
- Consider systemic corticosteroids
- Use conservative fluid management strategy
- Provide DVT and stress ulcer prophylaxis
- Ensure appropriate nutritional support
For Moderate ARDS (PaO₂/FiO₂ 101-200 mmHg):
- Implement higher PEEP strategy
- Avoid prolonged recruitment maneuvers
For Severe ARDS (PaO₂/FiO₂ ≤100 mmHg):
- Implement higher PEEP strategy
- Initiate prone positioning for >12 hours/day
- Consider neuromuscular blockade for 48 hours
- For refractory hypoxemia, consider VV-ECMO in selected patients
Monitoring and Complications
- Monitor for ventilator-associated pneumonia (occurs in 9-27% of intubated patients) 2
- Watch for barotrauma, volutrauma, and atelectrauma 2
- Assess daily for weaning readiness using spontaneous breathing trials 2
Prognosis
- Hospital mortality for ARDS ranges from 30-45%, increasing with severity of hypoxemia 2
- Survivors often experience decreased functional capacity, mental health issues, and reduced quality of life 3
Key Pitfalls to Avoid
- Excessive tidal volumes: Even in patients without ARDS, evidence suggests limiting tidal volumes is beneficial 4
- Inadequate PEEP: Zero PEEP is likely injurious; PEEP should be set to maximize alveolar recruitment while avoiding overdistention 4
- Delayed prone positioning: Early implementation (within 48 hours) is associated with better outcomes 2
- Fluid overload: Conservative fluid management is recommended to minimize pulmonary edema 2
- Prolonged recruitment maneuvers: These are now strongly recommended against in the 2024 ATS guideline 1
The 2024 American Thoracic Society guideline represents the most current evidence-based recommendations for ARDS management, updating previous guidelines with new recommendations on corticosteroids, VV-ECMO, neuromuscular blockers, and PEEP strategies 1.